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Background. Chemicals that store in lipid-rich compartments have the potential for long-term disruption of metabolic and
endocrine processes. Given the evidence that persistent organic pollutants (POPs) also alter systemic metabolic, endocrine, and
immunesystemfunctions,itfollowsthatelevatedchemicalconcentrationsinintra-abdominalfatmayalterfunction,throughlocal
chemical signaling, of visceral organs. Despite this potential, there has been little study deﬁning POP concentrations in live human
intra-abdominal fat. It is at present uncertain whether POPs distribute equally to all fat compartments, including fat in serum.
Methods.Sevenhumansubjectsscheduledforelectivesurgeryforbenignlesionsorcancerprovidedconsentforremovalofsamples
of subcutaneous and intra-abdominal fat and/or cancerous tissue. These samples were analyzed for 22 chlorinated pesticides and
10 polychlorinated biphenyl (PCB) congeners by GC/ECD plus GC/MS. Results. In only two subjects were the patterns and relative
concentrationsofPCBsandpesticidesaboutthesameinallfatcompartments.Intheothersubjects,thereweremajordiﬀerencesin
levelsinsubcutaneousascomparedtoothercompartments,butwithsomehigherandsomelower.WhilethepatternofPCBsinthe
variouscompartmentsmatchedthatofthepesticidesinsome,itwasoppositeinothers.Interpretation.Theseresultsdemonstratea
complicated distribution of PCB congeners and pesticides in various lipid compartments. The diﬀerence may reﬂect various Kows,
diﬀerent rates of metabolism, and/or diﬀerent lengths of exposure. But the results suggest that contaminant levels in serum or even
subcutaneous fat do not necessarily indicate concentrations and patterns in other kinds of adipose tissue.
1.Introduction
While adipose tissue has in the past been viewed as a depot
involved in passive storage of energy, it is increasingly clear
thatitisinfactahighlyactivetissue.Itisanendocrineorgan,
secreting various cytokines and regulating metabolism of
other organs. Adipose tissue aﬀects not only body weight,
but also insulin sensitivity, atherogenesis, blood pressure,
and other physiological functions [1]. The body has several
depots of white adipose tissue, of which the major two
categories are subcutaneous and visceral, although visceral
fat can be divided into subcategories of intraperitoneal,
retroperitoneal, and pelvic. Most studies have shown rela-
tively little diﬀerence in the fatty acid composition of the
various fat stores including fat in serum [2]. However,
there is suggestion that this may not be the case in obese
individuals [3] and Kishino et al. [4] reported that visceral
fat thickness was positively correlated to levels of palmitic
and saturate fatty acids in serum, but negatively correlated
with levels of linoleic and polyunsaturated fatty acids. There
is a growing body of evidence that many of the cytokines and
growth factors have depot-speciﬁc distribution in human
adipose tissue [5–7]. It is known that visceral fat correlates
better with the development of insulin insensitivity and the
metabolic syndrome than does subcutaneous fat, and this
may be related to the demonstrations that there is greater
glucose uptake [8] and insulin metabolism [9]i nv i s c e r a l
fat.
Persistent organic pollutants (POPs) are highly lipophilic
chemicals that bioaccumulate in animal and human fats [1].
POPs includes chemicals such as dioxins/furans, polychlori-
nated biphenyls (PCBs), chlorinated pesticides, brominated2 Journal of Environmental and Public Health
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Figure 1: Fat components. Organs are identiﬁed as follows: VC:
vena cava; A: aorta; P: pancreas; K: kidney; L: liver; S: stomach and
spleen; C: colon; U: uterus; B: bladder; P: prostate.
ﬂame retardants, and perﬂuorinated compounds. Because of
chlorine, bromine, or ﬂuoride groups on the hydrocarbon
rings or chains, these substances are resistant to degradation
both in the environment and in the human body. The
half-lives of substances such as DDE, the major metabolite
of DDT, and some PCB congeners are of the order of
5–10 years, and because of their presence in almost all
animal fat consumed with the diet, the concentrations in
the human body tend to increase with age because rates
of intake exceed those of metabolism and excretion [10].
While the manufacture and use of most of these chemicals
has been prohibited in the US through the Toxic Substances
Control Act of 1976 and their manufacture and use on
a global scale is outlawed by the Stockholm Convention
of the United Nations which entered into force in 2004,
these toxic chemicals remain present in the bodies of most
humans.
POPs are toxic to human health, being probable human
carcinogens, having immunosuppressive activity, causing
neurotoxicity, increasing risk of diabetes, cardiovascular
disease, and hypertension, and being endocrine disruptive
chemicals [11, 12]. Diﬀerent POPs often have somewhat
diﬀerent health outcomes, and most studies have focused on
only single chemicals. However, since essentially all humans
are exposed to many diﬀerent POPs, but perhaps in diﬀerent
relative concentrations, it is important to consider the
health eﬀects of chemical mixtures. Multiple chemicals may
have additive, less than additive, or synergistic eﬀects [13].
Because POPs are stored in adipose tissue and because the
various adipose tissues of the body have somewhat diﬀerent
endocrine functions, it is important to know whether or
not POPs distribute equally throughout all adipose tissues
and ultimately to determine how levels of these chemicals
inﬂuence the local adipose tissue. There is some evidence
that this may occur as Arsenescu et al. [14]h a v er e p o r t e d
that PCB 77 but not PCB 153 induces adipocyte diﬀer-
entiation and expression and release of proinﬂammatory
cytokines.
This preliminary study of analysis of PCBs and chlo-
rinated pesticides in various adipose tissues obtained from
seven human subjects is a ﬁrst attempt to determine whether
the distributions of several PCB congeners and several
chlorinated pesticides are the same in diﬀerent adipose
tissues.
2.MaterialsandMethods
Seven human subjects scheduled for elective surgery for
either benign lesions or cancer provided informed consent
for the surgical team to obtain blood and fat biopsies
from several diﬀerent fat compartments at the time of
surgery for analysis of ten PCB congeners and 22 chlorinated
pesticides. The study was reviewed and approved by the
local Institutional Review Board. Four subjects (3 males and
1 female) presented with renal cell carcinoma, 1 male had
a benign renal cyst, 1 male had a benign small intestinal
tumor, and 1 male had prostate cancer. All subjects had
preoperative CAT scans of the abdomen and pelvis, bone
scans, and complete blood metabolic studies. One surgeon
obtained the fat samples from all of the subjects during a
laparotomy. After blood samples were drawn, the surgeon
excised samples of 5 grams or greater from the subcutaneous
peripheral fat as well as from one or more intra-abdominal
fat stores, including visceral, retroperitoneal, and pelvic fat
as well as from the kidney or prostate that was removed at
surgery.
Visceral fat commonly refers to adipose tissue within
the peritoneal cavity. In some subjects, visceral fat from
three diﬀerent locations was obtained, the mesenteric fat
from around the small and large intestines, omental fat
from the folds of the peritoneum that connect the stomach
with other abdominal organs, and fat from the Falciform
ligament that attaches part of the liver to the diaphragm
and abdominal wall. Retroperitoneal fat lies posterior to
the peritoneal compartment and is separated from it by
the posterior peritoneum. Retroperitoneal fat surrounds the
adrenal glands, pancreas, kidneys, and the great vessels as
wellaslargelymphaticchannels.Thepelvicfatcompartment
is an inferior extension of the retroperitoneal fat and
surrounds the iliac vessels, rectum, bladder, and prostate in
males. The pelvic fat samples consisted of fat adjacent toJournal of Environmental and Public Health 3
the prostate and rectum. Figure 1 shows the location of the
various fat stores as well as the major abdominal organs.
Serum and fat samples were analyzed by Accu-Chem
Laboratories, Richardson, TX. PCBs and chlorinated pes-
ticides were extracted into hexane after the addition of
an internal standard (2,2 ,3,3 ,4,5,5 ,6-octachlorobiphenyl).
The solvent was then evaporated to dryness and the sample
reconstitutedandanalyzedonagaschromatograph(Hewlett
Packard 5890) equipped with an electron capture detector
using a Hewlett Packard 5970 mass spectrometer and a
DB5 capillary column. Three sets of standard references
were used, one from the national Institute of Standards
and Technology and two commercially available reference
sets. The level of detection was 0.15ng/mL and the level
of quantitation was 0.3ng/mL. Twenty three chlorinated
pesticides were measured, including hexachlorobenzene
(HCB),endrin,α,β,δ,andγ hexachlorocyclohexane(HCH),
heptachlor, heptachlor epoxide, α,a n dγ chlordane, oxy-
chlordane, trans-nonachlor, endosulfan I and II, endosulfan
sulfate, aldrin, dieldrin, dichlorodiphenyltrichloroethylene
(DDE), dichlordiphenyltrichlorethane (DDT), dichlorod-
iphenyldichloroethane (DDD), methoxychlor, mirex and
endrinaldehyde.TenPCBcongenerswereanalyzedincluding
PCBs 47 (2,2 ,4,4 ), 105 (2,3,3 ,4,4 ), 118 (2,3 ,4,4 ,5), 137
(2,2 ,3,4,4 ,5), 138 (2,2 ,3,4,4 ,5 ), 153 (2,2 4,4 ,5,5 ), 170
(2,2 3,3 4,4 ,5), 171 (2,2 3,3 ,4,4 ,6), 180 (2,2 3,4,4 5.5 ),
and 183 (2,2 3,4,4 ,5 ,6). All results are reported as wet
weightvalues,basedinpartonthebasisofthedemonstration
[15, 16] that lipid adjustment increases the bias in the
measurement. The limits of detection were 0.3ppb in serum,
10ppb in fat and kidney cancer tissue, and 35.7ppb in
cancerous tissue.
3. Results
Table 1 gives the results of pesticide levels in the various
samples from the seven subjects, while Table 2 provides
similar information for PCB congeners. Of the 23 pesticides
monitored, none of the samples showed levels of aldrin, α
and γ chlordane, δ and γ HCH, endosulfan II, endosulfan
sulfate, DDD, DDT, endrin aldehyde, or methoxychlor above
the level of quantitation, while for PCB congeners levels
of PCBs 47 and 171 were not found in any tissue at
concentrations above the levels of quantitation. Therefore,
these substances are not included in the tables.
Figure 2(a) shows the average levels of selected pesticides
in serum and various adipose tissues. Figure 2(b) shows the
same data without DDE, which is present at much higher
concentrations than any other pesticide. This ﬁgure clearly
shows that there are some diﬀerences in the patterns, most
strikingintheoneindividualfromwhomapelvicsamplewas
obtained. The diﬀerences are less clear for those tissues for
which more samples were obtained. Figure 3 shows a similar
plot of PCB results.
Figure 4 shows a plot of oxychlordane concentration in
visceral versus subcutaneous adipose tissues and demon-
strates that there is a very close relationship with an R2 of
0.939, P = .0003.
4. Discussion
The results of this investigation show a much more complex
picture for the distribution of pesticides and PCBs in various
adipose tissue pools than expected. It is usually assumed
that in a fasting person (all of these surgical patients were
fasting), POPs will be equally distributed in all adipose tissue
sites, and consequently one can obtain use serum samples
to monitor body burden of lipophilic substances. While
serum usually contains somewhere between 1–4% lipid, the
assumption is that the POPs concentrations in the serum
lipid fraction reﬂect all adipose tissue. In the past, results
were usually reported as lipid adjusted concentrations [17]
although reports that lipid-adjustment creates bias [16]h a v e
resulted in more reports of wet weight values or using serum
lipids as a covariate. Unfortunately, the sensitivity used in
the serum analyses in these subjects was not suﬃciently
sensitive so as to provide much basis for comparison,
but there is valuable data from the diﬀerent adipose tissue
sites.
It is clear that levels of individual POPs in any one
individual reﬂect both the degree and source of exposure,
the time since that exposure occurred, genetic diﬀerences
among individuals in rates of metabolism, body mass index
and, if female, number of pregnancies and whether or not
the child was breast fed. Most metabolism of POPs is a
result of activity of cytochrome P450s, and the ability to
metabolizeindividualPOPsvarieswithstructureandgenetic
susceptibility. For PCBs, for example, congeners with fewer
chlorines are in general more easily metabolized than those
with more chlorines [18]. Thus, an individual with major
exposure in the distant past will show a congener pattern
dominated by higher chlorinated congeners. However one
would assume that the same pattern would be found in the
various fat stores.
For PCBs, there is reasonably good correlation between
serum levels and those in subcutaneous fat for GK, HM,
and AS but not MS, GO, and JT. When comparing the
diﬀerent adipose tissues, there is a clear tendency for visceral
and retroperitoneal to have a greater percentage of higher
chlorinated congeners than subcutaneous fat for GK, GO
and JT. However, for ML subcutaneous and visceral patterns
were similar but concentrations higher than in retroper-
toneal fat. MS showed relatively similar patterns, but with
concentrations in mesenteric fat considerably greater than
in subcutaneous fat, while AS showed higher concentrations
in subcutaneous fat. HM, the only subject with pelvic fat,
showed relatively similar concentrations for PCBs 118, 138,
and170,buthighlevelsof153inpelvicbutnotsubcutaneous
and of 180 in subcutaneous but not pelvic fat.
Thepatternsamongthepesticidesalsoshowedsurprising
variability. DDE was present in the highest concentration
in most samples, but was below the detection limit in
subcutaneous fat in GK and JT in spite of being present
at high concentrations in serum and other adipose tissues.
In all other subjects, DDE concentrations were similar in
the diﬀerent adipose tissues. Dieldrin, heptachlor epoxide,
oxychlordane, and transnonachlor were present in most
adipose samples and had relatively similar distributions in4 Journal of Environmental and Public Health
T
a
b
l
e
1
:
P
e
s
t
i
c
i
d
e
s
(
p
p
b
w
e
t
w
e
i
g
h
t
)
i
n
v
a
r
i
o
u
s
a
d
i
p
o
s
e
t
i
s
s
u
e
s
a
n
d
s
e
r
u
m
.
(
—
i
n
d
i
c
a
t
e
s
v
a
l
u
e
s
b
e
l
o
w
t
h
e
l
i
m
i
t
o
f
d
e
t
e
c
t
i
o
n
)
.
P
e
s
t
i
c
i
d
e
s
(
p
p
b
w
e
t
w
e
i
g
h
t
)
G
K
D
D
E
D
i
e
l
d
r
i
n
E
n
d
o
s
u
l
f
a
n
1
E
n
d
r
i
n
H
C
B
H
e
p
t
o
c
h
l
o
r
H
e
p
t
o
c
h
l
o
r
e
p
o
x
i
d
e
α
H
C
H
β
H
C
H
M
i
r
e
x
O
x
y
c
h
l
o
r
d
a
n
e
T
r
a
n
s
-
n
o
n
a
c
h
l
o
r
S
e
r
u
m
1
.
3
—
—
—
—
—
—
—
—
1
.
6
—
—
S
u
b
c
u
t
a
n
e
o
u
s
—
—
—
—
3
1
.
8
—
—
—
—
—
4
6
.
9
—
V
i
s
c
e
r
a
l
M
e
s
e
u
t
e
r
i
c
3
5
1
.
7
1
5
.
4
—
—
—
—
1
1
.
2
1
9
.
3
3
4
.
5
—
6
3
.
3
5
4
.
4
O
m
e
n
t
a
l
2
7
7
.
6
2
3
—
—
—
—
—
—
—
—
5
4
.
4
4
6
.
4
F
a
l
c
i
f
o
r
m
l
i
g
a
m
e
n
t
4
3
6
.
5
1
5
.
8
9
4
.
9
—
—
—
1
1
.
5
—
1
7
—
8
3
.
3
7
0
.
3
R
e
t
r
o
p
e
r
i
t
o
n
e
a
l
4
2
7
.
6
2
5
.
4
—
—
—
—
1
2
.
3
—
2
0
.
7
—
8
7
.
3
7
1
.
9
M
L
D
D
E
D
i
e
l
d
r
i
n
E
n
d
o
s
u
l
f
a
n
E
n
d
r
i
n
H
C
B
H
e
p
t
o
c
h
l
o
r
H
e
p
t
o
c
h
l
o
r
e
p
o
x
i
d
e
α
H
C
H
β
H
C
H
M
i
r
e
x
O
x
y
c
h
l
o
r
d
a
n
e
T
r
a
n
s
-
n
o
n
a
c
h
l
o
r
S
e
r
u
m
0
.
4
—
—
—
—
0
.
3
—
—
—
—
—
S
u
b
c
u
t
a
n
e
o
u
s
2
7
6
.
2
T
r
a
c
e
—
—
T
r
a
c
e
—
1
3
.
8
—
T
r
a
c
e
—
2
5
1
7
.
3
V
i
s
c
e
r
a
l
2
2
2
.
1
T
r
a
c
e
E
n
d
o
s
u
l
f
a
n
1
—
T
r
a
c
e
—
1
0
.
9
—
T
r
a
c
e
—
2
7
.
4
1
5
.
9
R
e
t
r
o
p
e
r
i
t
o
n
e
a
l
1
1
7
.
8
—
—
—
T
r
a
c
e
—
T
r
a
c
e
T
r
a
c
e
T
r
a
c
e
—
1
0
.
3
—
G
e
r
o
t
a
’
s
1
7
4
.
3
—
—
—
T
r
a
c
e
—
—
—
T
r
a
c
e
—
1
0
.
9
—
H
M
D
D
E
D
i
e
l
d
r
i
n
E
n
d
o
s
u
l
f
a
n
1
E
n
d
r
i
n
H
C
B
H
e
p
t
o
c
h
l
o
r
H
e
p
t
o
c
h
l
o
r
e
p
o
x
i
d
e
α
H
C
H
β
H
C
H
M
i
r
e
x
O
x
y
c
h
l
o
r
d
a
n
e
T
r
a
n
s
-
n
o
n
a
c
h
l
o
r
S
e
r
u
m
1
.
5
—
—
—
—
—
—
—
—
—
—
—
S
u
b
c
u
t
a
n
r
o
u
s
6
4
7
.
5
2
3
.
1
—
—
5
1
.
2
—
1
1
.
4
1
3
.
8
1
1
5
.
2
—
1
7
.
5
3
0
.
2
P
e
l
v
i
c
1
0
0
9
.
1
—
—
—
1
4
1
—
3
0
.
6
1
1
2
7
9
.
8
—
3
0
.
2
5
4
.
4
M
S
D
D
E
D
i
e
l
d
r
i
n
E
n
d
o
s
u
l
f
a
n
1
E
n
d
r
i
n
H
C
B
H
e
p
t
o
c
h
l
o
r
H
e
p
t
o
c
h
l
o
r
e
p
o
x
i
d
e
α
H
C
H
β
H
C
H
M
i
r
e
x
O
x
y
c
h
l
o
r
d
a
n
e
T
r
a
n
s
-
n
o
n
a
c
h
l
o
r
S
e
r
u
m
0
.
7
6
—
—
—
—
—
—
—
—
—
—
—
S
u
b
c
u
t
a
n
e
o
u
s
5
7
9
.
2
1
6
—
—
—
—
2
3
.
9
—
1
5
.
5
—
6
0
.
5
1
4
4
.
7
V
i
s
c
e
r
a
l
-
(
M
e
s
e
n
t
e
r
i
c
)
4
6
6
.
6
4
8
.
2
2
0
.
3
—
—
—
2
3
.
2
—
—
—
5
5
.
4
1
4
9
.
4
A
S
D
D
E
D
i
e
l
d
r
i
n
E
n
d
o
s
u
l
f
a
n
1
E
n
d
r
i
n
H
C
B
H
e
p
t
o
c
h
l
o
r
H
e
p
t
o
c
h
l
o
r
e
p
o
x
i
d
e
α
H
C
H
β
H
C
H
M
i
r
e
x
O
x
y
c
h
l
o
r
d
a
n
e
T
r
a
n
s
-
n
o
n
a
c
h
l
o
r
S
e
r
u
m
3
.
1
—
—
—
0
.
3
—
—
—
T
r
a
c
e
—
0
.
3
0
.
4
S
u
b
c
u
t
a
n
e
o
u
s
l
7
4
3
.
7
—
—
—
—
—
—
—
1
0
4
.
4
—
2
3
6
.
4
1
9
4
V
i
s
c
e
r
a
l
9
6
0
.
6
1
6
.
6
—
—
—
—
2
0
.
8
—
1
4
0
.
9
—
3
2
3
.
9
2
5
8
.
6
G
O
D
D
E
D
i
e
l
d
r
i
n
E
n
d
o
s
u
l
f
a
n
1
E
n
d
r
i
n
H
C
B
H
e
p
t
o
c
h
l
o
r
H
e
p
t
o
c
h
l
o
r
e
p
o
x
i
d
e
α
H
C
H
β
H
C
H
M
i
r
e
x
O
x
y
c
h
l
o
r
d
a
n
e
T
r
a
n
s
-
n
o
n
a
c
h
l
o
r
S
e
r
u
m
0
.
3
—
—
—
—
—
—
—
—
—
—
—
S
u
b
c
u
t
a
n
e
o
u
s
8
1
9
.
3
—
—
—
—
—
1
4
.
2
—
3
4
.
3
—
1
2
4
.
4
1
3
0
.
8
V
i
s
c
e
r
a
l
6
9
8
.
1
1
3
.
5
—
—
—
—
1
5
.
4
—
3
6
.
3
—
1
3
8
.
4
1
3
9
.
4
R
e
t
r
o
p
e
r
i
t
o
n
e
a
l
(
P
e
r
i
r
e
n
a
l
)
7
0
0
.
4
—
—
—
—
—
1
2
—
3
1
.
5
—
1
0
4
.
3
1
1
2
.
4
J
T
D
D
E
D
i
e
l
d
r
i
n
E
n
d
o
s
u
l
f
a
n
1
E
n
d
r
i
n
H
C
B
H
e
p
t
o
c
h
l
o
r
H
e
p
t
o
c
h
l
o
r
e
p
o
x
i
d
e
α
H
C
H
β
H
C
H
M
i
r
e
x
O
x
y
c
h
l
o
r
d
a
n
e
T
r
a
n
s
-
n
o
n
a
c
h
l
o
r
S
e
r
u
m
6
.
3
—
—
—
—
—
—
—
—
—
0
.
3
—
S
u
b
c
u
t
a
n
e
o
u
s
—
—
—
—
—
—
1
2
.
1
—
—
—
5
9
.
1
—
V
i
s
c
e
r
a
l
M
e
s
e
n
t
e
r
i
c
2
1
4
7
.
7
1
3
4
—
—
—
—
3
4
.
7
—
4
8
.
3
—
1
8
9
.
9
2
4
6
.
2
O
m
e
n
t
a
l
1
1
7
0
.
3
1
4
.
9
1
9
8
.
2
—
—
—
1
2
.
5
—
1
9
.
8
—
6
6
.
6
1
2
0
.
7
R
e
t
r
o
p
e
r
i
t
o
n
e
a
l
(
G
e
r
o
t
a
’
s
)
1
4
2
6
.
4
2
1
.
7
1
6
2
.
5
—
—
—
2
1
.
9
—
2
5
.
4
—
1
1
4
.
3
1
6
2
.
6
T
u
m
o
r
(
k
i
d
n
e
y
)
—
—
—
—
—
—
—
—
—
—
1
2
.
2
—Journal of Environmental and Public Health 5
Table 2: PCBs in various fat compartments (ppb wet weight) (— indicates values below the limit of detection).
105 118 137 138 153 170 180 183 Total
GK
S e r u m ————0 . 60 . 40 . 6 —1 . 6
Subcutaneous — — — 21.5 39.1 18.8 32.1 — 111.5
Visceral
M e s e n t e r i c ————— 2 4 . 5 3 5 . 3 — 5 9 . 8
O m e n t a l ————— 2 1 . 5 3 3 . 5 —5 5
F a l c i f o r m l i g a m e n t ————— 1 7 . 8 2 6 . 8 — 4 4 . 6
R e t r o p e r i t o n e a l —————2 2 4 2 . 9 — 6 4 . 9
ML
Serum tr
Subcutaneous — 11.7 — 19.1 43.2 11.7 23.0 — 108.7
Visceral — Trace — 19.7 50.6 Trace — — 94.4
Retroperitoneal — Trace — Trace 21.4 — — — 32.6
Gerota’s — Trace — — 34.1 Trace — — 34.1
HM
S e r u m ——————0 . 4 —0 . 4
Subcutaneous — 20.9 — 18.5 — 28 56.7 — 124.1
Peloic — 44.4 — 19.6 67.6 23.5 — — 155.1
MS
S e r u m ———— 0 . 3 7 — 0 . 3 3 —0 . 7
Subcutaneous — 30.9 — 16.4 32.7 12.6 22.3 — 114.9
Visceral-mesenteric — 56.4 — 42.3 92.1 39.2 60.1 17.4 317.5
AS
Serum — 0.3 — 0.4 0.7 — 0.4 — 1.8
Subcutaneous — 21.7 — 31.7 50.2 18 35.2 — 156.8
Visceral — — — 24.2 — 13.7 27.8 — 65.7
GO
S e r u m ————0 . 4—0 . 3 —0 . 7
S u b c u t a n e o u s —————2 5 4 3 . 7 — 6 8 . 7
V i s c e r a l ————— 2 8 . 7 4 5 . 3 —7 4
R e t r o p e r i t o n e a l ( P e r i r e n a l ) ————— 2 7 . 9 4 2 . 7 — 7 0 . 6
JT
Serum — 0.6 — 1 1.4 0.4 0.8 — 4.2
Subcutaneous 13.9 — 12.3 84.8 158 38.3 75.9 18.8 402.3
Visceral
M e s e n t e r i c ————— 3 5 . 1 8 0 . 7 — 115.8
O m e n t a l ————— 3 9 . 8 8 9 . 7 — 129.5
R e t r o p e r i t o n e a l ( G e r o t a ’ s ) ————— 3 0 . 9 6 8 . 7 — 9 9 . 6
Tumor (kidney) ———— 1 9 . 2 —— — 1 9 . 2
all fat stores. βH C Hw a sp r e s e n ti nc o m p a r a b l ea m o u n t s
in most samples that contained measureable levels, and
αHCH was found in only a few samples. Interesting γHCH
(lindane) was not detected in any sample. Mirex was found
inserumatarelativelyhighconcentrationinGK,butwasnot
presentinanyadiposetissue,andsimilarsituationwasfound
with heptachlor in ML. These results suggest a very recent
exposuretothesetwoPOPsthathasnotyetequilibratedwith
adipose tissue.
When comparing general levels of PCBs to those of
the pesticides, distributions were similar for ML, HM,
and GO. However for AS and JT, PCBs were at higher
concentrations in subcutaneous fat, but pesticides were at
higher concentration in visceral and retroperitoneal fat. GK6 Journal of Environmental and Public Health
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Figure 2: (a) Average levels of elevated selected Chlorinated Pesticides found in serum and fats. (b) Average levels of elevated selected
Chlorinated Pesticides other than DDE found in serum and fats. The number of samples taken in the various compartments is the value of n.
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Figure 3: Average levels of PCB and selected components found
in serum and fats. The number of samples taken in the various
compartments is the value of n.
showed few pesticides in subcutaneous fat relative to other
stores. For MS levels of PCBs were greater in subcutaneous
than visceral fat, but levels of pesticides were approximately
equal in the two stores.
Only one cancerous tissue (kidney) gave detectible levels
of POPs, and it contained PCB 153 and oxychlorodane at
relatively low concentrations, but no other POPs. These
two POPs were present in the highest concentration in
subcutaneous fat. Since the lipid content of a tumor would
be expected to be signiﬁcantly less than adipose tissue, the
relative wet weight results are not surprising.
Itisunlikelythatthevariableresultsseeninlevelsofboth
PCB and pesticides are due to chance or to faulty chemical
analysis. There is always some variability in analysis of POPs,
but usually this is not more than 20%. The diﬀerences seen
are too large to be due to experiment variability.
There are a variety of possible explanations for these
surprising results. There are reports that there are large
diﬀerences in the average fatty acid composition between
individual subjects, as well as some diﬀerences in compo-
sition of diﬀerent adipose tissue sites within subjects [19].
If this is the case, it is possible that the lipid composition
o ft h ev a r i o u sa d i p o s et i s s u es t o r e si sr e ﬂ e c t e di nd i ﬀerent
solubility of individual POPs in diﬀerent depots even in the
same individual. There is not a lot of information on lipid
composition. Even subcutaneous fat taken from diﬀerent
parts of the body has been found to show between 2–10%
variation [2, 20]. There is some information suggesting thatJournal of Environmental and Public Health 7
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subcutaneous and visceral fats diﬀer more, with saturated
fats higher and monounsaturated fat lower in visceral than
subcutaneous fat [3].
Since P450 enzymes are found in almost all cells, not just
liver, it is conceivable that there is diﬀerent metabolism in
diﬀerent fat depots. Certainly there is evidence that diﬀerent
depots express diﬀerent endocrine factors. However, unless
the POPs were bound in some fashion, it seems unlikely that
even if there were diﬀerences in local metabolism that there
would not be a relatively rapid redistribution.
Botella et al. [21] reported on organochlorines pesticides
in serum and adipose tissue of Spanish women. They
reported six POPs where serum levels correlated relatively
well with those in adipose tissues, but no clear relationship
with the other nine POPs. The mean adipose/serum ratios
varied from 2.85 for endosulfan-ether to a high of 150.68
for DDE and 159.47 for endosulfan II. They questioned
the common assumption that serum concentrations are
indicative of those in adipose tissues. Our results are
consistent with their observations and indicate that the same
surprising relationship may also occur with diﬀerent PCB
congeners.
5. Limitations
There are major limitations to this study because of small
sample size, lack of measurement of the lipid content of
tissues, and the relatively low sensitivity of the analytical
methods. However, the diﬃculty in obtaining samples and
the lack of any comparable study elsewhere in light of the
overall importance of the question of how diﬀerent POPs
distribute in diﬀerent adipose tissue depots is justiﬁcation
for publishing these results. Replication is certainly needed
to conﬁrm the overall conclusion that POPs do not always
distribute equally among various lipid compartment in the
human body.
6. Conclusions
Contrary to expectations that patterns of various pesticides
and PCB congeners were not as similar as expected when
comparinglevelsinserum,subcutaneous,visceral,retroperi-
toneal, and pelvic fat. These results indicate that care should
be taken when assuming that serum levels of POPs reﬂect
patterns found in lipid stores throughout the body.
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